We are live on ! Find out more
IART icon

Integra LifeSciences

259 hedge funds and large institutions have $3.96B invested in Integra LifeSciences in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

31% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 36

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

23% more capital invested

Capital invested by funds: $3.23B → $3.96B (+$731M)

4% more funds holding

Funds holding: 248259 (+11)

0.56% less ownership

Funds ownership: 83.99%83.43% (-0.56%)

58% less call options, than puts

Call options by funds: $7.84M | Put options by funds: $18.5M

Holders
259
Holders Change
+11
Holders Change %
+4.44%
% of All Funds
5.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
47
Increased
100
Reduced
80
Closed
36
Calls
$7.84M
Puts
$18.5M
Net Calls
-$10.6M
Net Calls Change
-$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
LSERS
126
Louisiana State Employees Retirement System
Louisiana
$1.05M +$5.09K +100 +0.5%
MSL
127
Mackay Shields LLC
New York
$1.05M +$958K +18,811 New
Bank of Montreal
128
Bank of Montreal
Ontario, Canada
$1.04M +$261K +5,116 +37%
Thrivent Financial for Lutherans
129
Thrivent Financial for Lutherans
Minnesota
$1.02M +$18.4K +362 +2%
CCMINC
130
Cardinal Capital Management Inc (North Carolina)
North Carolina
$1M +$4.43K +87 +0.5%
JG
131
Jefferies Group
New York
$994K +$908K +17,835 New
SEC
132
Seven Eight Capital
New York
$990K +$905K +17,773 New
LCM
133
Laurion Capital Management
New York
$972K +$101K +1,991 +13%
AG
134
Aperio Group
California
$968K -$40.2K -790 -4%
Bessemer Group
135
Bessemer Group
New Jersey
$953K -$20.4K -400 -2%
GHCM
136
Glen Harbor Capital Management
California
$942K +$111K +2,176 +15%
AB
137
Amalgamated Bank
New York
$909K +$11.2K +219 +1%
DT
138
Diversified Trust
Tennessee
$892K
GC
139
Globeflex Capital
California
$865K
DBG
140
De Burlo Group
Massachusetts
$808K +$130K +2,544 +21%
NMERB
141
New Mexico Educational Retirement Board
New Mexico
$797K
GCP
142
GSA Capital Partners
United Kingdom
$796K +$728K +14,292 New
HCMT
143
Highland Capital Management (Tennessee)
Tennessee
$784K +$717K +14,071 New
MCIM
144
Meadow Creek Investment Management
Georgia
$776K +$91.3K +1,792 +15%
URS
145
Utah Retirement Systems
Utah
$744K +$7.54K +148 +1%
XK
146
Xact Kapitalforvaltning
Sweden
$736K
Boston Partners
147
Boston Partners
Massachusetts
$721K -$397K -7,792 -38%
MERSOM
148
Municipal Employees' Retirement System of Michigan
Michigan
$718K -$208K -4,090 -24%
NMIMC
149
Northwestern Mutual Investment Management Company
Wisconsin
$701K -$39.7K -779 -6%
COPPSERS
150
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$694K +$2.85K +56 +0.5%

IART Hedge Fund Activity: Q1 2019 in Review

259 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2019, worth a combined $3.96B — up 23% from $3.23B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new IART positions and 36 closed out — a net gain of 11 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $35.1M. The largest seller was Fidelity Investments, cutting an estimated $77.3M.

  • 259 institutional investors held Integra LifeSciences (IART) as of Q1 2019, up from 248 in Q4 2018.
  • Funds reported $3.96B of Integra LifeSciences stock for Q1 2019, up 23% quarter-over-quarter.
  • 47 funds opened new Integra LifeSciences positions in Q1 2019 and 36 closed out, a net change of +11 holders.
  • The largest Integra LifeSciences buyer in Q1 2019 was Janus Henderson Group, an estimated $35.1M added.
  • The largest Integra LifeSciences seller in Q1 2019 was Fidelity Investments, an estimated $77.3M sold.

Based on aggregated 13F filings for Q1 2019.